{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:57:50Z","timestamp":1786985870817,"version":"build-2736575974"},"reference-count":51,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["contemporaryclinicaltrials.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contemporary Clinical Trials"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.cct.2014.05.011","type":"journal-article","created":{"date-parts":[[2014,5,23]],"date-time":"2014-05-23T12:02:42Z","timestamp":1400846562000},"page":"304-313","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Flexible and extended dosing of nicotine replacement therapy or varenicline in comparison to fixed dose nicotine replacement therapy for smoking cessation: Rationale, methods and participant characteristics of the FLEX trial"],"prefix":"10.1016","volume":"38","clinical-trial-number":[{"clinical-trial-number":"nct01623505","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Heather","family":"Tulloch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Pipe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charl","family":"Els","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debbie","family":"Aitken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Clyde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Corran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert D.","family":"Reid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.cct.2014.05.011_bb0005","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.2105\/AJPH.92.6.1002","article-title":"Estimates of global and regional smoking prevalence in 1995, by age and sex","volume":"92","author":"Jha","year":"2002","journal-title":"Am J Public Health"},{"issue":"1","key":"10.1016\/j.cct.2014.05.011_bb0010","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1136\/tc.2009.032474","article-title":"Smoking estimates from around the world: data from the first 17 participating countries in the World Mental Health Survey Consortium","volume":"19","author":"Storr","year":"2010","journal-title":"Tob Control"},{"key":"10.1016\/j.cct.2014.05.011_bb0015","series-title":"Canadian Tobacco Use Monitoring Survey","author":"Health Canada","year":"2011"},{"issue":"1","key":"10.1016\/j.cct.2014.05.011_bb0020","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1360-0443.2004.00540.x","article-title":"Shape of the relapse curve and long\u2010term abstinence among untreated smokers","volume":"99","author":"Hughes","year":"2004","journal-title":"Addiction"},{"issue":"5","key":"10.1016\/j.cct.2014.05.011_bb0025","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD009329.pub2","article-title":"Pharmacological interventions for smoking cessation: an overview and network meta-analysis","volume":"5","author":"Cahill","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.cct.2014.05.011_bb0030","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.amepre.2008.04.009","article-title":"A clinical practice guideline for treating tobacco use and dependence: 2008 update. A U.S. Public Health Service report","volume":"35","author":"Fiore","year":"2008","journal-title":"Am J Prev Med"},{"issue":"6","key":"10.1016\/j.cct.2014.05.011_bb0035","doi-asserted-by":"crossref","first-page":"588","DOI":"10.3109\/07853890.2012.705016","article-title":"Comparisons of high-dose and combination nicotine replacement therapy, varenicline, and bupropion for smoking cessation: A systematic review and multiple treatment meta-analysis","volume":"44","author":"Mills","year":"2012","journal-title":"Ann Med"},{"issue":"8","key":"10.1016\/j.cct.2014.05.011_bb0040","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1056\/NEJM199708213370806","article-title":"Discrepancies between Meta-Analyses and Subsequent Large Randomized, Controlled Trials","volume":"337","author":"LeLorier","year":"1997","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.cct.2014.05.011_bb0045","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1001\/archgenpsychiatry.2009.142","article-title":"A randomized placebo-controlled clinical trial of five smoking cessation pharmacotherapies","volume":"66","author":"Piper","year":"2009","journal-title":"Arch Gen Psychiatry"},{"issue":"4","key":"10.1016\/j.cct.2014.05.011_bb0050","first-page":"771","article-title":"A randomized controlled open comparative trial of varenicline vs nicotine patch in adult smokers: efficacy, safety and withdrawal symptoms (the VN-SEESAW study)","volume":"74","author":"Tsukahara","year":"2010","journal-title":"Circ J Off J Japan Circ Soc"},{"issue":"8","key":"10.1016\/j.cct.2014.05.011_bb0055","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1136\/thx.2007.090647","article-title":"Varenicline versus transdermal nicotine patch for smoking cessation: results from a randomised open-label trial","volume":"63","author":"Aubin","year":"2008","journal-title":"Thorax"},{"issue":"2","key":"10.1016\/j.cct.2014.05.011_bb0060","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1161\/CIRCULATIONAHA.109.869008","article-title":"Efficacy and Safety of Varenicline for Smoking Cessation in Patients With Cardiovascular Disease A Randomized Trial","volume":"121","author":"Rigotti","year":"2010","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.cct.2014.05.011_bb0065","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.addbeh.2011.07.002","article-title":"Tobacco dependence treatment for hospitalized smokers: a randomized, controlled, pilot trial using varenicline","volume":"36","author":"Steinberg","year":"2011","journal-title":"Addict Behav"},{"issue":"3","key":"10.1016\/j.cct.2014.05.011_bb0070","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1378\/chest.10-0865","article-title":"Effects of Varenicline on Smoking Cessation in Patients With Mild to Moderate COPDA Randomized Controlled Trial","volume":"139","author":"Tashkin","year":"2011","journal-title":"CHEST J"},{"issue":"4","key":"10.1016\/j.cct.2014.05.011_bb0075","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.jsat.2010.03.007","article-title":"Smoking outcome by psychiatric history after behavioral and varenicline treatment","volume":"38","author":"McClure","year":"2010","journal-title":"J Subst Abuse Treat"},{"issue":"6","key":"10.1016\/j.cct.2014.05.011_bb0080","doi-asserted-by":"crossref","first-page":"390","DOI":"10.7326\/0003-4819-159-6-201309170-00005","article-title":"Effects of Varenicline on Smoking Cessation in Adults With Stably Treated Current or Past Major DepressionA Randomized Trial","volume":"159","author":"Anthenelli","year":"2013","journal-title":"Ann Intern Med"},{"issue":"12","key":"10.1016\/j.cct.2014.05.011_bb0085","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1001\/archgenpsychiatry.2011.83","article-title":"Effects of moderate-dose treatment with varenicline on neurobiological and cognitive biomarkers in smokers and nonsmokers with schizophrenia or schizoaffective disorder","volume":"68","author":"Hong","year":"2011","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"10.1016\/j.cct.2014.05.011_bb0090","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.schres.2011.02.003","article-title":"Varenicline for smoking cessation in people with schizophrenia: a double blind randomized pilot study","volume":"129","author":"Weiner","year":"2011","journal-title":"Schizophr Res"},{"issue":"5","key":"10.1016\/j.cct.2014.05.011_bb0095","doi-asserted-by":"crossref","first-page":"654","DOI":"10.4088\/JCP.11m07522","article-title":"A randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of varenicline for smoking cessation in patients with schizophrenia or schizoaffective disorder","volume":"73","author":"Williams","year":"2012","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"10.1016\/j.cct.2014.05.011_bb0100","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/15504263.2012.671067","article-title":"A Preliminary Feasibility Study of Varenicline for Smoking Cessation in Bipolar Disorder","volume":"8","author":"Wu","year":"2012","journal-title":"J Dual Diagn"},{"key":"10.1016\/j.cct.2014.05.011_bb0105","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.b3805","article-title":"Varenicline and suicidal behaviour: a cohort study based on data from the General Practice Research Database","volume":"339","author":"Gunnell","year":"2009","journal-title":"BMJ"},{"issue":"7","key":"10.1016\/j.cct.2014.05.011_bb0110","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1111\/add.12165","article-title":"Use of varenicline versus bupropion and risk of psychiatric adverse events","volume":"108","author":"Pasternak","year":"2013","journal-title":"Addiction"},{"key":"10.1016\/j.cct.2014.05.011_bb0115","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.f5704","article-title":"Smoking cessation treatment and risk of depression, suicide, and self harm in the Clinical Practice Research Datalink: prospective cohort study","volume":"347","author":"Thomas","year":"2013","journal-title":"Br Med J"},{"issue":"12","key":"10.1016\/j.cct.2014.05.011_bb0120","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1176\/appi.ajp.2013.12121599","article-title":"Varenicline, smoking cessation, and neuropsychiatric adverse events","volume":"170","author":"Gibbons","year":"2013","journal-title":"Am J Psychiatr"},{"key":"10.1016\/j.cct.2014.05.011_bb0125","series-title":"Beck Depression Inventory-2nd edition","author":"Beck","year":"1996"},{"key":"10.1016\/j.cct.2014.05.011_bb0130","series-title":"Treating tobacco use and dependence: 2008 update: Clinical practice guideline","author":"Fiore","year":"2008"},{"key":"10.1016\/j.cct.2014.05.011_bb0135","author":"Canadian Cancer Society"},{"key":"10.1016\/j.cct.2014.05.011_bb0140","author":"Canadian Mental Health Association"},{"issue":"1","key":"10.1016\/j.cct.2014.05.011_bb0145","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/ntr\/ntp165","article-title":"Smoking cessation for hospitalized smokers: An evaluation of the \u201cOttawa Model\u201d","volume":"12","author":"Reid","year":"2009","journal-title":"Nicotine Tob Res"},{"key":"10.1016\/j.cct.2014.05.011_bb0150","series-title":"Manual of smoking cessation: A guide for counsellors and practitioners","author":"McEwen","year":"2008"},{"issue":"3","key":"10.1016\/j.cct.2014.05.011_bb0155","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1360-0443.2004.00995.x","article-title":"Outcome criteria in smoking cessation trials: proposal for a common standard","volume":"100","author":"West","year":"2005","journal-title":"Addiction"},{"issue":"9","key":"10.1016\/j.cct.2014.05.011_bb0160","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1111\/j.1360-0443.1991.tb01879.x","article-title":"The Fagerstr\u00f6m test for nicotine dependence: a revision of the Fagerstrom Tolerance Questionnaire","volume":"86","author":"Heatherton","year":"1991","journal-title":"Br J Addict"},{"issue":"1","key":"10.1016\/j.cct.2014.05.011_bb0165","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0306-4603(94)90049-3","article-title":"Reliability of the Fagerstrom tolerance questionnaire and the Fagerstrom test for nicotine dependence","volume":"19","author":"Pomerleau","year":"1994","journal-title":"Addict Behav"},{"key":"10.1016\/j.cct.2014.05.011_bb0170","series-title":"State-trait anxiety inventory for adults: sampler set: manual, test, scoring key: Mind Garden","author":"Spielberger","year":"1983"},{"key":"10.1016\/j.cct.2014.05.011_bb0175","series-title":"State-Trait Anger Expression Inventory: Professional manual: Psychological Assessment Resources Odessa, FL","author":"Spielberger","year":"1988"},{"issue":"3","key":"10.1016\/j.cct.2014.05.011_bb0180","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1001\/archpsyc.1986.01800030107013","article-title":"Signs and symptoms of tobacco withdrawal","volume":"43","author":"Hughes","year":"1986","journal-title":"Arch Gen Psychiatry"},{"issue":"3","key":"10.1016\/j.cct.2014.05.011_bb0185","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/j.1360-0443.2005.01289.x","article-title":"A comparison of the psychometric properties of three cigarette withdrawal scales","volume":"101","author":"Etter","year":"2006","journal-title":"Addiction"},{"key":"10.1016\/j.cct.2014.05.011_bb0190","series-title":"The Mini International Neuropsychiatric Interview Version 6.0 (MINI 6.0)","author":"Sheehan","year":"2009"},{"key":"10.1016\/j.cct.2014.05.011_bb0195","first-page":"22","article-title":"The Mini-International Neuropsychiatric Interview (MINI): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"59","author":"Sheehan","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.cct.2014.05.011_bb0200","series-title":"Morbidity and Mortality Weekly Report","article-title":"Vital Signs - Current Cigarette Smoking Among Adults Aged\u2265 18 Years with Mental Illness\u2014United States, 2009\u20132011","author":"Morbidity and Mortality Weekly Report","year":"2013"},{"issue":"12","key":"10.1016\/j.cct.2014.05.011_bb0205","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.2105\/AJPH.2009.188136","article-title":"Smoking characteristics of adults with selected lifetime mental illnesses: results from the 2007 National Health Interview Survey","volume":"100","author":"McClave","year":"2010","journal-title":"Am J Public Health"},{"issue":"1","key":"10.1016\/j.cct.2014.05.011_bb0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1037\/a0018327","article-title":"Smoking cessation: next steps for special populations research and innovative treatments","volume":"78","author":"Borrelli","year":"2010","journal-title":"J Consult Clin Psychol"},{"issue":"1","key":"10.1016\/j.cct.2014.05.011_bb0215","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1749-6632.2011.06202.x","article-title":"Socioeconomic status and smoking: a review","volume":"1248","author":"Hiscock","year":"2012","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"10.1016\/j.cct.2014.05.011_bb0220","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/1462220021000060428","article-title":"Hardening and the hard-core smoker: concepts, evidence, and implications","volume":"5","author":"Warner","year":"2003","journal-title":"Nicotine Tob Res"},{"issue":"8","key":"10.1016\/j.cct.2014.05.011_bb0225","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1093\/ntr\/ntq103","article-title":"\u201cHardcore\u201d definitions and their application to a population-based sample of smokers","volume":"12","author":"Costa","year":"2010","journal-title":"Nicotine Tob Res"},{"issue":"2","key":"10.1016\/j.cct.2014.05.011_bb0230","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1080\/10550490590924728","article-title":"Co\u2010Morbidity of Smoking in Patients with Psychiatric and Substance Use Disorders","volume":"14","author":"Kalman","year":"2005","journal-title":"Am J Addict"},{"issue":"12","key":"10.1016\/j.cct.2014.05.011_bb0235","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1080\/14622200802443569","article-title":"Tobacco use and cessation in psychiatric disorders: National Institute of Mental Halth report","volume":"10","author":"Ziedonis","year":"2008","journal-title":"Nicotine Tob Res"},{"key":"10.1016\/j.cct.2014.05.011_bb0240","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1146\/annurev.publhealth.012809.103701","article-title":"Confronting a neglected epidemic: tobacco cessation for persons with mental illnesses and substance abuse problems","volume":"31","author":"Schroeder","year":"2010","journal-title":"Annu Rev Public Health"},{"issue":"7","key":"10.1016\/j.cct.2014.05.011_bb0245","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1111\/j.1360-0443.2010.02946.x","article-title":"Smoking cessation in severe mental illness: what works?","volume":"105","author":"Banham","year":"2010","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.cct.2014.05.011_bb0250","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.neubiorev.2011.06.007","article-title":"Smoking, quitting, and psychiatric disease: A review","volume":"36","author":"Aubin","year":"2012","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.cct.2014.05.011_bb0255","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e2856","article-title":"Risk of cardiovascular serious adverse events associated with varenicline use for tobacco cessation: systematic review and meta-analysis","volume":"344","author":"Prochaska","year":"2012","journal-title":"Br Med J"}],"container-title":["Contemporary Clinical Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714414000792?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714414000792?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,3]],"date-time":"2018-10-03T20:50:10Z","timestamp":1538599810000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551714414000792"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":51,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S1551714414000792"],"URL":"https:\/\/doi.org\/10.1016\/j.cct.2014.05.011","relation":{},"ISSN":["1551-7144"],"issn-type":[{"value":"1551-7144","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Flexible and extended dosing of nicotine replacement therapy or varenicline in comparison to fixed dose nicotine replacement therapy for smoking cessation: Rationale, methods and participant characteristics of the FLEX trial","name":"articletitle","label":"Article Title"},{"value":"Contemporary Clinical Trials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cct.2014.05.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}